Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide

Hepatitis B virus (HBV) infection is associated with the risk of osteoporosis and bone mineral density (BMD) loss. Tenofovir alafenamide (TAF) is associated with a slightly lower degree of BMD loss compared with tenofovir disoproxil, without loss of the excellent anti-HBV effects. The aim of the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Takuma, Ichikawa, Tatsuki, Miyaaki, Hisamitsu, Miuma, Satoshi, Motoyoshi, Yasuhide, Yamashima, Mio, Yamamichi, Shinobu, Koike, Makiko, Nakano, Yusuke, Honda, Tetsurou, Yajima, Hiroyuki, Miyazaki, Osamu, Kuribayashi, Yasutaka, Ikeda, Tomonari, Taura, Naota, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652643/
https://www.ncbi.nlm.nih.gov/pubmed/34900255
http://dx.doi.org/10.3892/br.2021.1489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652643/
https://www.ncbi.nlm.nih.gov/pubmed/34900255
http://dx.doi.org/10.3892/br.2021.1489

Ejemplares similares